About 22,010 people will be diagnosed with AML. Most cases will be in adults. About 11,090 people will die from AML. Again, most of these deaths will be in adults. AML accounts for about 1 out of 3 ...
This early unblinding will yield 30 subjects with Annamycin (190mg/m2 and 230/m2 ... AnnAraC for the treatment of subjects with AML as both first line therapy and for subjects who are refractory ...
Received US Institutional Review Board (IRB) approval for pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) and engaged leading contract research organization (CRO); On track to begin ...
CBW also provided correspondent wire services to foreign banks in high-risk jurisdictions such as Lebanon, Brazil and Cyprus, according to the FDIC notice, yet its AML software, a program called ...
Background: This study aims to identify the hub genes and immune-related pathways in acute myeloid leukemia (AML) to provide new theories for immunotherapy. Methods: We use bioinformatics methods to ...
CB-012, a clinical-stage allogeneic anti-CLL-1 CAR-T cell therapy for acute myeloid leukemia The FDA granted Fast Track and Orphan Drug designations to CB-012 for relapsed or refractory acute ...